Total Regulatory T cells (Treg) serve as a crucial marker for understanding immune regulation and potential autoimmune dysregulation within the body. Tregs, a subset of T cells characterized by the expression of CD4, CD25, and the transcription factor FoxP3, play an essential role in maintaining immune tolerance by suppressing the activation and proliferation of effector T cells that could otherwise attack self-antigens and cause autoimmune disease.
The assessment of Treg levels through the Lymphocyte MAP panel offers insights into the body's ability to regulate immune responses, distinguishing between healthy immune function and conditions characterized by immune imbalance. By evaluating Treg levels in conjunction with other immune cell profiles provided by the panel, clinicians can gain a comprehensive understanding of an individual's immune health, aiding in the diagnosis and management of autoimmune disorders, inflammatory conditions, and the overall assessment of immune system resilience. This quantification of Tregs, therefore, not only underscores the complexity of the immune system's regulatory mechanisms but also highlights the potential for targeted therapeutic interventions aimed at restoring immune balance and preventing the progression of immune-mediated diseases.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.